Insider Transactions in Q4 2023 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 01
2023
|
Mark A Meltz COO GENERAL COUNSEL SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-1.89%
|
$1,082
$2.25 P/Share
|
Dec 01
2023
|
Neha Krishnamohan CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,459
-2.18%
|
$2,918
$2.25 P/Share
|
Dec 01
2023
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-0.79%
|
$1,082
$2.25 P/Share
|